Park West Asset Management LLC Viking Therapeutics, Inc. Transaction History

Park West Asset Management LLC

$1.26 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.4 - $94.5 $1.04 Million - $5.67 Million	60,000 New	60,000 $4.92 Million
Q1 2022 May 16, 2022	BUY	$3.0 - $4.88 $2.55 Million - $4.15 Million	850,000 Added 52.51%	2,468,587 $7.41 Million
Q4 2021 Feb 14, 2022	SELL	$4.6 - $6.72 $229,999 - $336,000	-50,000 Reduced 3.0%	1,618,587 $7.45 Million
Q2 2021 Aug 16, 2021	BUY	$5.19 - $6.73 $366,414 - $475,138	70,600 Added 4.42%	1,668,587 $10 Million
Q1 2021 May 17, 2021	BUY	$5.74 - $9.67 $613,732 - $1.03 Million	106,922 Added 7.17%	1,597,987 $10.1 Million
Q4 2020 Feb 16, 2021	BUY	$5.3 - $6.71 $177,857 - $225,174	33,558 Added 2.3%	1,491,065 $8.4 Million
Q2 2020 Aug 14, 2020	SELL	$4.35 - $8.08 $609,000 - $1.13 Million	-140,000 Reduced 8.76%	1,457,507 $10.5 Million
Q1 2020 May 15, 2020	BUY	$3.45 - $7.95 $180,890 - $416,834	52,432 Added 3.39%	1,597,507 $7.48 Million
Q4 2019 Feb 14, 2020	SELL	$6.38 - $8.73 $1.29 Million - $1.77 Million	-202,432 Reduced 11.58%	1,545,075 $12.4 Million
Q2 2019 Aug 14, 2019	BUY	$7.67 - $10.63 $1.34 Million - $1.86 Million	175,000 Added 11.13%	1,747,507 $14.5 Million
Q1 2019 May 15, 2019	SELL	$7.58 - $9.94 $758,000 - $994,000	-100,000 Reduced 5.98%	1,572,507 $15.6 Million
Q4 2018 Feb 14, 2019	BUY	$7.16 - $16.21 $2.89 Million - $6.54 Million	403,400 Added 31.79%	1,672,507 $12.8 Million
Q3 2018 Nov 14, 2018	BUY	$9.7 - $19.65 $8.29 Million - $16.8 Million	855,000 Added 206.47%	1,269,107 $22.1 Million
Q2 2018 Aug 14, 2018	SELL	$3.88 - $12.74 $333,264 - $1.09 Million	-85,893 Reduced 17.18%	414,107 $3.93 Million
Q1 2018 May 15, 2018	SELL	$4.11 - $6.93 $411,000 - $693,000	-100,000 Reduced 16.67%	500,000 $2.19 Million
Q4 2017 Feb 14, 2018	BUY	$1.74 - $4.34 $696,000 - $1.74 Million	400,000 Added 200.0%	600,000 $2.44 Million
Q3 2017 Nov 14, 2017	BUY	$0.94 - $1.91 $188,000 - $382,000	200,000	200,000 $382,000

Others Institutions Holding VKTX

# of Institutions

442

Shares Held

63.3M

Call Options Held

6.23M

Put Options Held

2.97M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.83B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park West Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park West Asset Management LLC with notifications on news.

Account